Sustained scleral stiffening in rats after a single genipin treatment.
Ontology highlight
ABSTRACT: Scleral stiffening has been proposed as a therapy for glaucoma and myopia. Previous in vivo studies have evaluated the efficacy of scleral stiffening after multiple treatments with a natural collagen crosslinker, genipin. However, multiple injections limit clinical translatability. Here, we examined whether scleral stiffening was maintained after four weeks following a single genipin treatment. Eyes from brown Norway rats were treated in vivo with a single 15 mM genipin retrobulbar injection, sham retrobulbar injection, or were left naive. Eyes were enucleated either 1 day or four weeks post-injection and underwent whole globe inflation testing. We assessed first principal Lagrange strain of the posterior sclera using digital image correlation as a proxy for scleral stiffness. Four weeks p
SUBMITTER: Hannon BG
PROVIDER: S-EPMC6833323 | biostudies-literature | 2019 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA